Showing results (31-40 of 70) with videos related to
Sort By:
Pageof 7
Human Cell|November 28, 2016
Establishment and characterization of a novel uterine carcinosarcoma cell line, TU-ECS-1, with mutations of TP53 and KRASYohei Chiba, Seiya Sato, Hiroaki Itamochi, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 4, 2009
Preoperative and intraoperative assessments of depth of myometrial invasion in endometrial cancerShinya Sato, Hiroaki Itamochi, Muneaki Shimada, et al.Clinical Case Reports|July 1, 2021
Primary breast lymphoma initially diagnosed as invasive ductal carcinoma: A case reportNatsuki Uenaka, Shinya Yamamoto, Seiya Sato, et al.International Journal of Clinical Oncology|July 5, 2014
Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapyImari Deura, Muneaki Shimada, Keiko Hirashita, et al.Journal of Clinical Medicine|August 28, 2025
The Construct and Predictive Validity of the Japanese Version of the Intensive Care Unit Mobility ScaleKohei Tanaka, Nobuto Nakanishi, Shinichi Watanabe, et al.Molecular and Clinical Oncology|October 21, 2021
Underdiagnosis of early cervical cancer with an invisible cervical transformation zone in an elderly patient: A case reportMasako Ishikawa, Kentaro Nakayama, Hitomi Yamashita, et al.International Journal of Clinical Oncology|November 29, 2015
Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasiaAkiko Kudoh, Shinya Sato, Hiroaki Itamochi, et al.Molecular and Clinical Oncology|July 1, 2021
Single-port laparoscopic surgery for ovarian cystectomy: A single-center analysis of 25 casesKentaro Nakayama, Yuki Yoshimura, Sultana Razia, et al.Anticancer Research|August 2, 2019
Evaluating Chemotherapy-induced Nausea and Vomiting and Food Intake in Patients With Gynecologic CancerHiroaki Komatsu, Tetsuro Oishi, Shinya Sato, et al.Healthcare (Basel, Switzerland)|April 28, 2023
Promising Therapeutic Impact of Immune Checkpoint Inhibitors in Type II Endometrial Cancer Patients with Deficient Mismatch Repair StatusKiyoka Sawada, Kentaro Nakayama, Sultana Razia, et al.Pageof 7